Consistent with these findings, treatment of human breast cancer MDA-MB-231 cells with HGF induced activation of Abl kinases as measured by phosphorylation of CrkL Y207, and this phosphorylation was blocked by the Abl inhibitor STI571 (S5A Fig). The gene discussed is CRKL; the disease is breast carcinoma.